nVerses Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
nVerses Capital's KURA Position: Q3 2026 in Review
nVerses Capital sold out of Kura Oncology (KURA) in Q3 2026, closing a stake of 26,023 shares — an estimated $285K sold.
nVerses Capital first reported a position in KURA in Q3 2024 and held it in 2 quarters. The position peaked at $285K in Q2 2026. 230 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- nVerses Capital reported no remaining Kura Oncology position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 26,023 Kura Oncology shares in Q3 2026, an estimated $285K.
- nVerses Capital first reported a position in Kura Oncology in Q3 2024 and held it in 2 quarters.
- nVerses Capital's Kura Oncology position peaked at $285K in Q2 2026.
- 230 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.